


Harold D.
Efficient and easy
In stock · arrives 2 to 4 working days after payment
Pay by card or PayPal (confirmed instantly), Instant EFT, EFT or crypto
Damaged or wrong? We replace or refund
Packed and shipped from Cape Town, South Africa. Dispatched within 24 to 36 hours, then tracked courier (Aramex or The Courier Guy) to your door in 1 to 3 working days.
An amylin-receptor agonist. Amylin is the hormone co-secreted with insulin that signals satiety, so it sits in a different pathway to GLP-1 compounds like Retatrutide. Current research pairs the two classes rather than treating them as alternatives.
Both are amylin-class. Eloralintide is the newer and more selective of the two, which is exactly why it is being studied — a cleaner receptor profile makes results easier to attribute.
First batch is inbound. It is listed as sold out until it physically lands and its certificate of analysis is published — we do not sell stock we do not hold.
The short version: Eloralintide is Eli Lilly's amylin receptor agonist, built to be more selective than cagrilintide. A 48-week phase 2 trial reported up to 20% weight loss, and phase 3 started in late 2025.
Eloralintide (Lilly code LY3841136) is an amylin-type peptide, the same family as cagrilintide. The difference is selectivity. In Lilly's cell tests it preferred the human amylin 1 receptor, about 12 times more than the calcitonin receptor, while cagrilintide hits both. In rats it caused less taste avoidance, a lab marker linked to nausea, than cagrilintide, and it cut food intake and body weight, mostly through fat loss.
A phase 1 trial in 48 healthy people tested single doses. Side effects were mostly mild, and the drug's profile fitted once-weekly use.
The phase 2 trial (The Lancet, 2025) enrolled 263 adults with obesity or overweight and no type 2 diabetes at 46 US centres. After 48 weeks, average weight loss ranged from 9% at the lowest dose to 20% at the highest doses tested, against 0.4% on placebo. Nausea and fatigue were the most common side effects, and fatigue was notable, reaching over 40% in some higher-dose groups.
Lilly then launched the ENLIGHTEN phase 3 programme. ENLIGHTEN-2 (type 2 diabetes) started in December 2025 and ENLIGHTEN-1 (no diabetes) in February 2026, with further trials in sleep apnoea and knee pain.
One phase 2 trial is the whole efficacy record so far, run by the company that makes it, in a mostly female and mostly white US group. No phase 3 results exist yet and it is not approved anywhere. The trial results belong to Lilly's material and do not describe a research vial.
It arrives as a freeze-dried powder. Once bacteriostatic water goes in, it belongs in the fridge. Our reconstitution and storage guide covers the details, and the calculator does the maths.
The picky amylin agonist: strong phase 2 numbers, phase 3 only just under way.
For research use only. Not for human consumption. Nothing on this page is medical advice.
No reviews from orders with Eloralintide yet. Here is what recent customers said about ordering from us.
★★★★★
Efficient and easy
Harold D. · 18 Nov 2026
★★★★★
I went on holiday and stressed that I would not get my research materials in time, but you and the delivery company did not disappoint! Thank you for excellent pre order advice on products, user friendly ordering system, and superb delivery system!!!
Nicoleen · 18 Nov 2026
★★★★★
You guys are the best. Prices are good and service is outstanding
Glenda S. · 17 Nov 2026
★ 4.9 across all 117 AP reviews, good and bad. See them. Every reviewer gets R100 store credit, whatever they rate.
Follow my channel — every couple of weeks I drop one genuinely useful thing: how to read a COA, reconstitution math, the odd honest deal. No spam, no hype.
Follow Lab Notes on WhatsAppFree · follow & mute anytime · research use only. New here? WELCOME99 = R99 off a first order of R400 or more (doesn’t stack with sale discounts) →
Please read before entering this website.
All products offered on this website are strictly intended for scientific research and laboratory use only. They are not intended for human consumption, veterinary use, or any other purpose outside of controlled research environments.
These products have not been evaluated, approved, or certified by the South African Health Products Regulatory Authority (SAHPRA), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), or any other regulatory authority for use in humans or animals.
By entering this website you confirm that:
AP accepts no liability for misuse of any product sold on this platform.
Join our email list and we’ll put WELCOME99 on your basket now: R99 off a first order of R400 or more. You’ll get restock news and the odd offer. Unsubscribe any time.
One use per email, first order only. Doesn’t stack with sale discounts. Research use only.
It’s on your basket: R99 off your first order of R400 or more.
Go to checkoutWe only deliver in South Africa for now. Tell us where you are, and we’ll let you know if we start delivering there.
We only use this to tell you about delivery to your country.
We’re counting where people want delivery. The countries with the most interest come first.
Chats are read by the AP team to help you. Never share card details here. Prefer a person? WhatsApp us